• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录中介因子2核受体盒肽与雌激素受体α共激活因子结合位点的相互作用

Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.

作者信息

Wärnmark Anette, Treuter Eckardt, Gustafsson Jan-Ake, Hubbard Roderick E, Brzozowski Andrzej M, Pike Ashley C W

机构信息

Department of Biosciences at Novum, Karolinska Institutet, S-14157 Huddinge, Sweden.

出版信息

J Biol Chem. 2002 Jun 14;277(24):21862-8. doi: 10.1074/jbc.M200764200. Epub 2002 Apr 5.

DOI:10.1074/jbc.M200764200
PMID:11937504
Abstract

The activation function 2/ligand-dependent interaction between nuclear receptors and their coregulators is mediated by a short consensus motif, the so-called nuclear receptor (NR) box. Nuclear receptors exhibit distinct preferences for such motifs depending both on the bound ligand and on the NR box sequence. To better understand the structural basis of motif recognition, we characterized the interaction between estrogen receptor alpha and the NR box regions of the p160 coactivator TIF2. We have determined the crystal structures of complexes between the ligand-binding domain of estrogen receptor alpha and 12-mer peptides from the Box B2 and Box B3 regions of TIF2. Surprisingly, the Box B3 module displays an unexpected binding mode that is distinct from the canonical LXXLL interaction observed in other ligand-binding domain/NR box crystal structures. The peptide is shifted along the coactivator binding site in such a way that the interaction motif becomes LXXYL rather than the classical LXXLL. However, analysis of the binding properties of wild type NR box peptides, as well as mutant peptides designed to probe the Box B3 orientation, suggests that the Box B3 peptide primarily adopts the "classical" LXXLL orientation in solution. These results highlight the potential difficulties in interpretation of protein-protein interactions based on co-crystal structures using short peptide motifs.

摘要

核受体与其共调节因子之间的激活功能2/配体依赖性相互作用由一个短共有基序介导,即所谓的核受体(NR)框。核受体对这类基序表现出不同的偏好,这既取决于结合的配体,也取决于NR框序列。为了更好地理解基序识别的结构基础,我们对雌激素受体α与p160共激活因子TIF2的NR框区域之间的相互作用进行了表征。我们确定了雌激素受体α的配体结合结构域与来自TIF2的Box B2和Box B3区域的12聚体肽之间复合物的晶体结构。令人惊讶的是,Box B3模块显示出一种意想不到的结合模式,这与在其他配体结合结构域/NR框晶体结构中观察到的典型LXXLL相互作用不同。该肽沿着共激活因子结合位点移动,使得相互作用基序变为LXXYL而非经典的LXXLL。然而,对野生型NR框肽以及为探测Box B3方向而设计的突变肽的结合特性分析表明,Box B3肽在溶液中主要采用“经典”的LXXLL方向。这些结果突出了基于使用短肽基序的共晶体结构来解释蛋白质-蛋白质相互作用时可能存在的困难。

相似文献

1
Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.转录中介因子2核受体盒肽与雌激素受体α共激活因子结合位点的相互作用
J Biol Chem. 2002 Jun 14;277(24):21862-8. doi: 10.1074/jbc.M200764200. Epub 2002 Apr 5.
2
Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.通过螺旋8-9环在ERRα同二聚体界面与PGC-1α结合表面之间进行通讯。
J Biol Chem. 2008 Jul 18;283(29):20220-30. doi: 10.1074/jbc.M801920200. Epub 2008 Apr 25.
3
Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.共激活因子肽对雌激素和抗雌激素与雌激素受体的结合具有不同的稳定作用。
Mol Endocrinol. 1999 Nov;13(11):1912-23. doi: 10.1210/mend.13.11.0373.
4
Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.人雌激素相关受体α(ERRα)非配体依赖性转录激活的证据:ERRα配体结合结构域与过氧化物酶体增殖物激活受体辅激活因子-1α复合物的晶体结构
J Biol Chem. 2004 Nov 19;279(47):49330-7. doi: 10.1074/jbc.M407999200. Epub 2004 Aug 26.
5
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.雌激素受体/共激活因子识别的结构基础以及他莫昔芬对这种相互作用的拮抗作用。
Cell. 1998 Dec 23;95(7):927-37. doi: 10.1016/s0092-8674(00)81717-1.
6
Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.配体决定共激活因子核受体(NR)盒对雌激素受体亚型的亲和力。
Mol Endocrinol. 2001 Jun;15(6):909-22. doi: 10.1210/mend.15.6.0649.
7
The coactivator LXXLL nuclear receptor recognition motif.共激活因子LXXLL核受体识别基序。
J Pept Res. 2004 Mar;63(3):207-12. doi: 10.1111/j.1399-3011.2004.00126.x.
8
Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.共激活因子糖皮质激素受体相互作用蛋白1(GRIP1)和类固醇受体共激活因子1(SRC-1)的核受体结合位点:具有不同结合特异性的多个基序
Mol Endocrinol. 1998 Feb;12(2):302-13. doi: 10.1210/mend.12.2.0065.
9
Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.利用重组肽文库筛选雌激素受体β和甲状腺激素受体β特异性共激活剂模拟肽
Mol Endocrinol. 2000 May;14(5):605-22. doi: 10.1210/mend.14.5.0445.
10
Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.雄激素受体对FXXLF和LXXLL基序的不同识别模式。
Mol Endocrinol. 2004 Sep;18(9):2132-50. doi: 10.1210/me.2003-0375. Epub 2004 Jun 3.

引用本文的文献

1
TENT5C functions as a corepressor in the ligand-bound glucocorticoid receptor and estrogen receptor α complexes.TENT5C在配体结合的糖皮质激素受体和雌激素受体α复合物中作为共抑制因子发挥作用。
FEBS J. 2025 May 27. doi: 10.1111/febs.70137.
2
A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for Cell-Membrane Permeable Inhibitors for the Interaction Between Estrogen Receptor α and Coactivator SRC1.一种环化螺旋-环-螺旋肽作为雌激素受体α与共激活因子SRC1相互作用的细胞膜可渗透抑制剂的分子支架。
Chembiochem. 2025 Jul 11;26(13):e202500232. doi: 10.1002/cbic.202500232. Epub 2025 Jun 20.
3
Look What You Made Me Do: Discerning Feature for Classification of Endocrine-Disrupting Chemical Binding to Steroid Hormone Receptors.
看看你让我做了什么:用于识别内分泌干扰化学物质与类固醇激素受体结合的分类特征。
J Chem Inf Model. 2025 Apr 28;65(8):4148-4162. doi: 10.1021/acs.jcim.4c02288. Epub 2025 Apr 8.
4
Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.卵巢癌中的核受体:癌症治疗范式的转变
Front Oncol. 2024 Jul 15;14:1383939. doi: 10.3389/fonc.2024.1383939. eCollection 2024.
5
Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs.雌激素受体-α靶向作用:PROTACs、SNIPERs、肽- PROTACs、抗体偶联PROTACs和SNIPERs。
Pharmaceutics. 2022 Nov 19;14(11):2523. doi: 10.3390/pharmaceutics14112523.
6
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.乳腺癌中的雌激素受体 alpha 和 ESR1 突变。
Adv Exp Med Biol. 2022;1390:171-194. doi: 10.1007/978-3-031-11836-4_10.
7
Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants.人雌激素受体α拮抗剂,第 3 部分:3-D 药效团和 3-D QSAR 指导布雷菲德菌素 A 从头化合物优化,以开发新型乳腺癌抑制剂。
Molecules. 2022 Apr 28;27(9):2823. doi: 10.3390/molecules27092823.
8
Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer.定义构象开关的能量基础,该构象开关介导乳腺癌中突变雌激素受体的配体非依赖性激活。
Mol Cancer Res. 2021 Sep;19(9):1559-1570. doi: 10.1158/1541-7786.MCR-20-1017. Epub 2021 May 21.
9
A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment.一种与雌激素不敏感相关的 ERα 突变形式会影响配体结合和共激活因子募集之间的偶联。
Sci Signal. 2020 Sep 22;13(650):eaaw4653. doi: 10.1126/scisignal.aaw4653.
10
Estrogen receptor signaling mechanisms.雌激素受体信号转导机制。
Adv Protein Chem Struct Biol. 2019;116:135-170. doi: 10.1016/bs.apcsb.2019.01.001. Epub 2019 Feb 4.